CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...